Lung cancer patients' care needs during immunotherapy
Part of Cancer, Lungs & breathing clinical trials.
This study aims to understand the care needs of people with lung cancer who are receiving or have received immunotherapy. By participating, you can help improve support for other patients going through similar treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a lung cancer diagnosis, confirmed by a doctor through imaging or biopsy.
- You are currently receiving or have previously received immunotherapy for your lung cancer.
- You are at least 20 years old.
- You can communicate in Mandarin or Taiwanese.
- You are able to complete a questionnaire and are willing to participate.
- You are able to provide informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the physical and emotional needs of people with advanced cancer who are receiving immunotherapy. It aims to understand how these needs affect quality of life.
This study looks at how patients with advanced lung cancer feel during their treatment, which combines chemotherapy, radiation, and an immunotherapy drug. The goal is to understand and improve quality of life during therapy.
This study uses a computer model to predict how immunotherapy for lung cancer may affect your quality of life. It aims to help doctors better manage side effects and improve your daily well-being during treatment.
This study is a survey to learn about the experiences and feelings of people with non-small cell lung cancer who are taking immunotherapy drugs. The goal is to understand how you're doing on treatment, which can help improve care for others.
This study aims to understand how maintenance immunotherapy affects fatigue in people with non-small cell lung cancer. Researchers will talk with patients to learn about their experiences.
This study is looking at how the immune system responds to immunotherapy in people with advanced non-small cell lung cancer. By collecting sputum (mucus from your lungs) and blood samples, researchers hope to find clues that could help predict treatment outcomes.
Hear when a new Lung Cancer, Immunotherapy, Quality of Life, Symptom Severity, Care Needs trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.